CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1983; 33:74-86
doi: 10.3322/canjclin.33.2.74
© 1983 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jett, J. R.
Right arrow Articles by Fontana, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jett, J. R.
Right arrow Articles by Fontana, R. S.

CA: A Cancer Journal for Clinicians, Vol 33, 74-86, Copyright © 1983 by American Cancer Society


Lung Cancer: Current Concepts and Prospects

James R. Jett M.D.1, Denis A. Cortese M.D.1, and Robert S. Fontana M.D.2

1 Assistant Professor of Medicine of Mayo Medical School and Consultant in the Division of Thoracic Diseases and Internal Medicine of Mayo Clinic and Mayo Foundation in Rochester, Minnesota.
2 Professor of Medicine of Mayo Medical School and Consultant in the Division of Thoracic Diseases and Internal Medicine of Mayo Clinic and Mayo Foundation in Rochester, Minnesota.

In the United States, lung cancer is now the leading cancer killer among men, and it will soon be the leader among women. Most lung cancers are attributable to cigarette smoking.

Symptomatic lung cancer tends to be advanced and unresectable. Chest roentgenography and sputum cytology are the only techniques proved capable of detecting presymptomatic, early-stage disease.

Treatment of lung cancer depends primarily on the cell type and the extent of the tumor. Small cell cancer tends to be widespread, and the favored treatment is combination chemotherapy. For non-small cell cancer, the treatment of choice, whenever possible, is surgical resection.

Efforts directed toward early detection and treatment have failed to reduce lung cancer mortality substantially. Thus, primary prevention through control of cigarette smoking remains the single most important measure for combating this frustrating disease.




This article has been cited by other articles:


Home page
ThoraxHome page
G. Loewen, N. Natarajan, D. Tan, E. Nava, D. Klippenstein, M. Mahoney, M. Cummings, and M. Reid
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment
Thorax, April 1, 2007; 62(4): 335 - 340.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. Garg, R. L. Keith, T. Byers, K. Kelly, A. L. Kerzner, D. A. Lynch, and Y. E. Miller
Randomized Controlled Trial with Low-Dose Spiral CT for Lung Cancer Screening: Feasibility Study and Preliminary Results
Radiology, November 1, 2002; 225(2): 506 - 510.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by American Cancer Society.